Experimental pills target devastating Muscle-Wasting disease in children and adults
NCT ID NCT03639701
Summary
This clinical trial is testing whether two oral supplements (deoxythymidine and deoxycytidine) can help people with a rare genetic disorder called TK2 deficiency. TK2 deficiency causes severe muscle weakness, walking difficulties, and fatigue by reducing the body's cellular energy production. The study aims to see if these supplements can boost energy production and improve symptoms in 23 participants with confirmed genetic mutations.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MITOCHONDRIAL DNA DEPLETION SYNDROME 2 MYOPATHIC TYPE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Columbia University Irving Medical Center
New York, New York, 10032, United States
Conditions
Explore the condition pages connected to this study.